Volume Outcome Relationships and Effects
NCT06343597 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2026-03-20
Summary
This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities.
Conditions
- Esophageal Cancer
Sponsors & Collaborators
-
Methodist Health System
lead OTHER
Principal Investigators
-
Dhiresh Jeyarajah, MD · Methodist Health System
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-15
- Primary Completion
- 2027-06-15
- Completion
- 2028-06-15
Countries
- United States
Study Locations
More Related Trials
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
NCT05370144 ·Status: RECRUITING ·Phase: NA
-
The Intensive Nutritional Support in Esophageal Cancer Undergoing Neoadjuvant Therapy
NCT07067359 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002631 ·Status: COMPLETED ·Phase: PHASE3
-
The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC)
NCT06828718 ·Status: ACTIVE_NOT_RECRUITING
-
Retrospective Review of Esophageal Cancer at MSKCC
NCT05706558 ·Status: RECRUITING
-
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy
NCT03223662 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant Treatment Modalities in Esophageal Cancer
NCT04821843 ·Status: RECRUITING ·Phase: PHASE3
-
Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical Research
NCT05831150 ·Status: NOT_YET_RECRUITING
-
The Application of 3T MRI in Esophageal Cancer
NCT03635619 ·Status: UNKNOWN
-
RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY
NCT05570487 ·Status: UNKNOWN
-
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
NCT00551759 ·Status: TERMINATED ·Phase: PHASE2
-
Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC
NCT04759235 ·Status: UNKNOWN
-
Textbook Outcomes After Oesophagectomy in Regional Australia
NCT06721715 ·Status: NOT_YET_RECRUITING
-
Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant Chemoradiotherapy
NCT06061263 ·Status: UNKNOWN
-
Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial
NCT07211009 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Detection of (Sub)Clinical Toxicity in Irradiated vs. Non-irradiated Surgically Treated Esophageal Cancer Patients: a Pilot Study (CROSS SECT)
NCT03396614 ·Status: COMPLETED
-
Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer
NCT01558648 ·Status: COMPLETED
-
Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma
NCT03413436 ·Status: COMPLETED ·Phase: PHASE4
-
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology
NCT03462524 ·Status: COMPLETED
-
Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma
NCT01472419 ·Status: COMPLETED
-
Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma
NCT07067450 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
NCT04046575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma
NCT03381651 ·Status: COMPLETED ·Phase: NA
-
Frailty In Thoracic Surgery for Esophageal Cancer
NCT04145726 ·Status: UNKNOWN